Combination therapy with Chinese medicine and ACEI/ARB for the management of diabetic nephropathy: The promise in research fragments

Current Vascular Pharmacology

Volumn 13, Issue 4, 2015, Pages 526-539

  Tu, Xiang ^a   Ye, XueFeng ^a   Xie, ChunGuang ^a   Chen, Jing ^a   Wang, Fei ^a   Zhong, Sen ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Chinese Medicine; Combination therapy; Diabetic nephropathy

Indexed keywords

ABELMOSCHUS MANIHOT EXTRACT; ADVANCED GLYCATION END PRODUCT; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BAILING CAPSULE; BENAZEPRIL; CAPTOPRIL; CHINESE DRUG; COLLAGEN TYPE 4; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; GLUCOSE; LOSARTAN; MILKVETCH EXTRACT; NITROGEN; PLACEBO; RETINOL BINDING PROTEIN; SAFFLOWER YELLOW EXTRACT; SHENKANGWAN; SUPEROXIDE DISMUTASE; TANGSHENLING; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UREA; XIAOTONG MAINING GRANULE; YISHEN PAIZHUO; ZHEN WU TANG; ZHIXIAO BAOSHEN NING GRANULE; ZHIXIAO WENSHEN NING GRANULE; HERBACEOUS AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BENAZEPRIL; BLOOD VISCOSITY; CHINESE MEDICINE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPOTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MULTICENTER STUDY (TOPIC); NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL SYSTEM PARAMETERS; SAFFLOWER YELLOW EXTRACT; WESTERN MEDICINE; YANG DEFICIENCY; YIN DEFICIENCY; COMBINATION DRUG THERAPY; DIABETIC NEPHROPATHIES; PROCEDURES; TREATMENT OUTCOME;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84938688083     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161112666141014153410     Document Type: Article

References (71)

1. Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010; 8: 62.
2. Zhuo L, Zou G, Li W, Lu J, Ren W. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res 2013; 18: 4.
3. Liu H, Peng Y, Li J, et al. Stages of 3,547 patients with chronic kidney disease and relevant factor analysis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010; 35(5): 499-510.
4. St Peter WL, Odum LE, Whaley-Connell AT. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease. Pharmacotherapy 2013; 33(5): 496-514.
5. Wong J. Is there benefit in dual renin- angiotensin-aldosterone system blockade? No, yes and maybe: a guide for the perplexed. Diab Vasc Dis Res 2013; 10(3): 193-201.
6. Liu CS, Gong ZZ, Xiang SH. Clinical study on integrative Chinese and Western medicine in treating allergic purpura and preventing renal impairment. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24(8): 701-3.
7. Zhu LQ, Liu YH, Huang M, Wei H, Liu Z. Study on improvement of islet beta cell function in patients with latent autoimmune diabetes mellitus in adults by integrative Chinese and Western medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24(7): 581-4.
8. Deferrari G, Ravera M, Berruti V, Leoncini G, Deferrari L. Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. J Am Soc Nephrol 2004; 15(Suppl 1): S6-S11.
9. Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 1995; 10(11): 1963-74.
10. Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia 2012; 55(3): 566-78.
11. Hollenberg NK, Fisher ND, Price DA. Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system. Hypertension 2000; 32: 387-92.
12. Fernandez-Juárez G, Barrio V, de Vinuesa SG, Goicoechea M, Praga M, Luño J. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials. J Am Soc Nephrol 2006; 17(12 Suppl 3): S250-4.
13. MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 2006; 48(1): 8-20.
14. Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med 2007; 24(5): 486-93.
15. China Association of Chinese Medicine. Guideline for TCM Diabetes Prevention and Treatment. 1st ed. China Press of Traditional Chinese Medicine: Beijing 2008; p 16.
16. Wang Mei, Yu JN, Wang Yan. Preliminary exploration in the therapeutic strategies and prescription laws of TCM for the management of diabetic nephropathy in modern literature. Chin J Integr Trad Western Nephrol 2011; 12(3): 259-60.
17. Wang SF, Tang S, Cao KG. Analysis on medication rule of traditional Chinese medicine in treating diabetic nephropathy. Tianjin J Trad Chin Med 2009; 26(2): 167-8.
18. National Kidney Foundation. KDOQI Clinical practice guideline for diabetes and ckd: 2012 update. Am J Kidney Dis 2012; 60(5): 850-86.
19. Liu YH, Yang L, Liu J. Clinical observation on treatment of early diabetic nephropathy by milkvetch injection combined with captopril. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25(11): 993-5.
20. Guo DZ, Wang YH, Chen ZQ. Effect of treatment in 39 patients with diabetic nephropathy by safflower yellow and benazepril in combination. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28(4): 360-3.
21. Wang YZ, Wang XX, Wang HC. Clinical observation on treatment of diabetic nephropathy with Chinese drugs combined with benazepril. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27(8): 683- 5.
22. Yu JY, Xiong NN, Guo HF. Clinical observation on diabetic nephropathy treated with alcohol of Abelmoschus manihot. Zhongguo Zhong Xi Yi Jie He Za Zhi 1995; 15(5): 263-5.
23. Song J, Li YH, Yang XD. Effect of combined therapy with bailing capsule and benazepril on urinary albumin excretion rate and Creactive protein in patients with early diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29(9): 791-3.
24. Li JP, He XL, Li Q. Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26(5): 415-8.
25. Wang SD, Huang YY, Li Jing, et al. The effects of TCM prevention and treatment strategy on renal function and lipid metabolism in renal deficiency compensatory period patients with diabetic nephropathy. Beijing J Trad Chin Med 2007; 26(4): 211-4.
26. Zhang LF, Zhao JX, Lv RH, et al. Study on effectiveness and safety of optimum program for prevention and treatment of renal insufficiency of diabetic nephropathy. J Trad Chin Med 2006; 47(10): 755-8.
27. Li JY, Tan YZ, Feng GY, He L, Zhou LG, Lu H. Advances of genetics in diabetic nephropathy. Yi Chuan 2012; 34(12): 1537-44.
28. Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton) 2012; 17(5): 480-7.
29. El-Baz R, Settin A, Ismaeel A, et al. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 2012; 13(4): 472-7.
30. So WY, Wang Y, Ng MC, et al. Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients. Diabetes Care 2008; 31(11): 2148-53.
31. Hong XP, Zhang XZ, He XL, Huang XZ, Chen HR, Wang YZ. Effect of Astragalus mongholicus on renal gene expression profile in mice with diabetic nephropathy. Zhongguo Zhong Yao Za Zhi 2008; 33(6): 676-80.
32. Luo Ren, Cheng YB, Zhong XY. Study on correlation between therapeutic effect and ACE gene in diabetic nephropathy treated by "Minor Four and Five Decoction". Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 2001; 15(1): 24- 6.
33. Feng CG, Zhang LX, Liu X. Progress in research of aldose reductase inhibitors in traditional medicinal herbs. Zhongguo Zhong Yao Za Zhi 2005; 30(19): 1496-500.
34. Yang HZ, Zhou MM, Zhao AH, Xing SN, Fan ZQ, Jia W. Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro. Zhong Yao Cai 2009; 32(8): 1259-61.
35. Li XZ, Yan HD, Wang J. Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011; 31(4): 525-31.
36. Tang DY, Guo SS, Sun RY. Effect of xianzhen tablet on content of advanced glycosylation end products (AGEs) and mRNA expression of AGE-specific cellular receptor in renal cortex of diabetic rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25(1): 60-3.
37. Nakagawa T, Yokozawa T, Terasawa K, Nakanishi K. Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy. J Pharm Pharmacol 2003; 55(2): 219-27.
38. Sobhia ME, Grewal BK, Bhat J, Rohit S, Punia V. Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies. Expert Opin Ther Targets 2012; 16(3): 325- 44.
39. Piao YL, Liang XC, Yang N, Yin DH, Zuo PP. Effect of Tujian decoction on protein kinase C activity in renal cortex in diabetic rat. Zhongguo Zhong Yao Za Zhi 2004; 29(7): 685-9.
40. Long HB, Zhang H, Zhong J, Zhu Y, He JH, Wei LB. Protective effects of Shenkangwan against podocyte injury in rats with early diabetic nephropathy. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28(7): 1268-72.
41. Zhang M, Liu M, Xiong M, Gong J, Tan X. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol 2012; 141(1): 111-8.
42. Cai Y, Chen J, Jiang J, Cao W, He L. Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats. J Ethnopharmacol 2010; 131(1): 88-94.
43. Li LL, Chen ZQ, Wang YH, et al. Relationship between urinary nephrin and urinary albumin changes in diabetic rats and effects of yiqiyangyinhuayutongluo recipe. J Trad Chin Med 2012; 32(2): 278-82.
44. Ju JW, Mu SH, Yin YZ, Lü CK, Sun XY, Deng LX. Effects of zao huang mixture (see text) on the expressions of TGF-beta1 and Col IV in human glomerular mesangial cells cultured in high glucose environment. J Trad Chin Med 2011; 31(2): 127-9.
45. Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. J Ethnopharmacol 2011; 138(3): 731-6.
46. Xu HQ, Hao HP. Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model. Biol Pharm Bull 2004; 27(7): 1014-8.
47. Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Horm Metab Res 2006; 38(2): 82-8.
48. Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009; 32(2): 220-4.
49. Lee SH, Kim YS, Lee SJ, Lee BC. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. J Ethnopharmacol 2011; 137(3): 1409-14.
50. Wang F, Lu F, Xu L. Effects of Houttuynia cordata thumb on expression of BMP-7 and TGF-beta1 in the renal tissues of diabetic rats. J Trad Chin Med 2007; 27(3): 220-5.
51. Liu S, Tang LQ, Chen LM, Chen XQ, Zhang ST, Wei Y. Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy. Zhongguo Zhong Yao Za Zhi 2008; 33(1): 68-72.
52. Ji XM, Wang Q, Gong MX, Du YQ, Jia DX. Effects of Xiaoke granule on transforming growth factor-beta1 expression and proliferation in rat mesangial cells. Chin Med J (Engl) 2006; 119(21): 1839-42.
53. Sun WS, Wu XL, Qiao CL. Clinical study on effect of tongluo capsule in treating diabetic nephropathy caused chronic renal failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24(8): 704-6.
54. Wang HY, Bao JL. Effect of houttuynia cordata aetherolea on adiponectin and connective tissue growth factor in a rat model of diabetes mellitus. J Trad Chin Med 2012; 32(1): 58-62.
55. Wu YL, Wei C, Wang HT. Effect of tongshenluo capsule on the components of extracellular matrix and their metabolism in kidney of rats with diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27(4): 326-30.
56. Zheng LY, Wen XY, Xu MW. Modulative effect of zhenqing recipe on expressions of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in experimental type 2 diabetic rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26(Suppl): 72-6.
57. Jiang ZS, Zhang SL, Yan H. Study on syndrome-type in TCM and its correlation with superoxide dismutase and malonyldialdehyde in patients with non-insulin dependent diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997; 17(10): 597-8.
58. Yokozawa T, Yamabe N, Kim HY, et al. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Biol Pharm Bull 2008; 31(7): 1422-8.
59. Xu H, Shen J, Liu H, Shi Y, Li L, Wei M. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol 2006; 84(12): 1267-73.
60. He LQ, Cao HX, Shen YJ. Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy. Zhong Xi Yi Jie He Xue Bao 2003; 1(2): 119-21.
61. Wenzhuo D, Haimin G, Jiafu W, et al. Preventing and treating actions of compound lian zhu capsule on micrangium lesions in diabetic rats. J Trad Chin Med 2005; 25(2): 148-52.
62. Jiang ZS, Zhang SL, Cai XJ. Effect of salvia miltiorrhiza composita on superoxide dismutase and malonyldialdehyde in treating patients with non-insulin dependent diabetes mellitus (NIDDM). Zhongguo Zhong Xi Yi Jie He Za Zhi 1997; 17(1): 32-4.
63. Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 2012; 30(1): 49-59.
64. Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) 2013; 124(3): 139-52.
65. Wang Q, Kuang H, Su Y, et al. Naturally derived antiinflammatory compounds from Chinese medicinal plants. J Ethnopharmacol 2013; 146(1): 9-39.
66. Gui D, Huang J, Guo Y, et al. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. Cytokine 2013; 61(3): 970-7.
67. Reeves WB, Rawal BB, Abdel-Rahman EM, Awad AS. Therapeutic modalities in diabetic nephropathy: future approaches. Open J Nephrol 2012; 2(2): 5-18.
68. Dou C, Wan Y, Sun W, et al. Mechanism of Chinese herbal medicine delaying progression of chronic kidney disease. Zhongguo Zhong Yao Za Zhi 2009; 34(8): 939-43.
69. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354(13): 1387-401.
70. Chen J, Wan Y, Bian R, et al. Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy. Zhongguo Zhong Yao Za Zhi 2010; 35(4): 525-30.
71. Zhang Le, Yan MH, Xiao Ya, Xie HJ, Zhao XS, Luo R. Analysis of the direction of clinical research for diabetic nephropathy treated by TCM/Chinese and western medicine. J Trop Med 2011; 11(3): 278-81.